For general education, not medical advice. This guide can’t diagnose you or replace care from your own clinician. If you’re worried about a spot or symptom, see a board-certified dermatologist.
Melanoma is a skin cancer that can spread to other parts of the body. Most cases are found early. Early disease is highly treatable.1 This guide explains the types and stages. It can help you see where a diagnosis fits and what care may follow.
Key points
- The cancer may sit in the top skin layer, grow deeper, or spread. These stages need different care.
- Most early cases are cured with surgery. Disease that has spread may need drugs from a cancer team.2
- Stage helps predict the outlook. A new or changing mole is a warning sign.
What is melanoma?
Melanoma starts in the cells that give skin its color, called melanocytes. It may start in a mole or as a new spot. It can grow anywhere, even on the soles, palms, or under a nail. Sunlight and tanning beds raise the risk. So do many moles, fair skin, and a family history. It can spread, so a changing spot needs a check.
The melanoma family: where a diagnosis fits
The team checks how deep it has grown and whether it has spread. These findings set the stage:
- Melanoma in situ (Stage 0). Cancer cells sit only in the top skin layer. They cannot spread while they remain truly in situ. Surgery to clear the edges usually cures it. The melanoma in situ guide covers this. One type on skin with years of sun damage is lentigo maligna (see the lentigo maligna guide).
- Stage I–II. The cancer has grown deeper into the skin but has not spread to other sites. Depth and a break in the surface help set its stage. Surgery is the main treatment. Some high-risk cases also need drugs.
- Stage III–IV melanoma. Stage III means spread to nearby lymph nodes or nearby skin or lymph channels. Stage IV means spread to distant sites. Surgery may still play a role. Drug treatment depends on the stage and whether the cancer can be removed.3
There are also subtypes. Superficial spreading is the most common. Nodular types can grow down fast. Lentigo maligna melanoma is the invasive form that grows from lentigo maligna. Acral types grow on palms, soles, or under nails. Stage guides much of the treatment, but type and site also matter.
Warning signs: the ABCDEs
A new or changing mole is the most important clue. The ABCDE guide helps spot a worrisome mole:
- Asymmetry: one half does not match the other
- Border: edges are ragged, notched, or blurred
- Color: more than one color, or uneven color
- Diameter: larger than a pencil eraser (about 6 mm), though melanomas can be smaller
- Evolving: changing in size, shape, color, or feel, or a new spot
Another simple clue is the "ugly duckling": a mole that looks different from your others. Anything new, changing, bleeding, or itchy is worth getting checked.
How it is diagnosed and staged
The clinician checks the spot, often with a lighted lens. A suspicious spot needs a biopsy. The aim is to remove the whole spot with a small margin when practical. A large spot or one in a hard-to-reach site may need a sample of just part.2
If cancer is found, the report gives its Breslow thickness. This is its depth in millimeters. Thin tumors tend to have a better outlook. Thickness and a break in the surface (ulceration) help set the stage. The team also checks whether it has spread to lymph nodes, nearby skin, or distant sites. Stage guides treatment.4
Treatment, by stage
Treatment follows the stage. Here is the short version of each; the deeper guides cover the details.
Melanoma in situ
Stage 0 cancer is removed with a margin of skin. Clear edges usually mean a cure. For lentigo maligna, a specialist may offer a cream or radiation if surgery is not suitable or is declined. These need close checks. Proof of lasting cure is less certain than for surgery. The melanoma in situ guide covers this in full.
Invasive melanoma
For cancer that has grown deeper, surgery is the main treatment. The surgeon removes a margin of normal skin. Its width depends on the depth of the tumor.56
Some people need care beyond surgery. An oncology team may offer drug treatment after surgery for high-risk stage II disease, even when no lymph nodes are involved. For stage III–IV disease, the team chooses care based on where the cancer is and whether it can be removed.3 Other options in selected settings include:
- Radiation can be added after surgery in certain higher-risk situations, used when surgery is not a good option, or given to ease symptoms.2
- Neoadjuvant immunotherapy means immunotherapy given before surgery, for higher-risk melanoma that can still be removed. It is used in selected patients.7
- Intralesional or limb-directed therapy uses an injection into the tumor, or treatment delivered to an affected arm or leg. These approaches may be used for cancer in nearby skin or lymph channels ("in-transit" disease). The options depend on whether it can be removed.83
Checking the lymph nodes
For thicker melanomas, a sentinel lymph node biopsy may be offered. This checks the first lymph node the melanoma would drain to. It is mainly a staging tool. The result helps predict outlook and decide whether to discuss more treatment.9 The trial did not show a clear survival gain for the whole group. If that node has melanoma, doctors now often watch the area with ultrasound rather than removing all the nodes, because removing them did not improve survival in a large trial.10
Advanced melanoma
For stage III–IV melanoma, the plan may include surgery, drug treatment, or both. An oncology team coordinates the drugs:
- Immunotherapy helps the immune system attack the melanoma. After surgery for higher-risk disease it lowers the chance of return, and for spread melanoma it has meaningfully improved long-term survival.1112
- Targeted pills (BRAF/MEK inhibitors) are an option for the roughly half of melanomas that carry a BRAF gene change, found by gene testing.13
This care is coordinated by referral to a medical oncologist.
Other options patients ask about
Black salve or Cansema. Do not use these to remove a mole or melanoma. They can kill healthy skin while leaving cancer behind. A scab or a flat scar does not prove a cure. Tissue studies show harm and cancer that remained after use.1415
Home mole removal. Do not cut, burn, freeze, or use acids on a mole. Even vinegar has caused burns when used this way. A biopsy lets the team find out if a spot is melanoma and measure its depth. Home removal can damage the tissue needed for that test.162
Natural cures, diets, herbs, or supplements. None has been shown to cure melanoma. Some products interact with cancer drugs. Tell your care team what you use. Support for pain, stress, or nutrition can help during treatment, but should not replace care that treats the cancer.17
Creams instead of surgery. An off-label cream is sometimes used for lentigo maligna when surgery is not suitable. This does not make it a treatment for invasive melanoma. No home cream can show how deep a melanoma is. Ask which type you have before weighing treatment choices.2
Waiting or declining care. Melanoma can spread, so do not wait for a changing spot to hurt. Arrange a prompt check. If treatment feels too hard because of other illness, cost, or fear, tell the team. A plan can weigh treatment, symptom relief, and your goals. Leaving a suspected melanoma unchecked is not a safe substitute for that discussion.3
Lowering your risk and catching it early
Sunlight and tanning beds raise risk. Use shade, protective clothes, and sunscreen. One trial follow-up found fewer melanomas with daily sunscreen, but the overall result was uncertain. The result was clearer for invasive disease. It was not clear for in situ disease.18 Know your skin. Have a new or changing spot checked.
Use shade, protective clothes, sunscreen, and avoid tanning beds. In one trial follow-up, daily sunscreen users had fewer melanomas, but the overall result was uncertain. The reduction was clearer for invasive melanoma; in-situ results were uncertain.
Know your skin and have new or changing spots checked. Finding a thin tumor is linked with a better outlook. This does not prove that routine screening lowers deaths for everyone.
Whole-body prevention, separate from the spot treatments above. “No effect” means good trials found no benefit. Every source is PubMed-verified; not medical advice.
Check your skin often. If you are at higher risk, ask how often you need a full skin exam. See the skin self-exam guide for how to do it.
When to see a doctor
Have a spot checked if it is new, changing, growing, or bleeding. Do the same if it looks unlike your other spots. Do not wait for pain. Many moles, unusual moles, fair skin, or a family history may mean you need more frequent exams.
Worried about a spot?
SpotDoc offers full-body skin cancer screening in Brownwood Square, The Villages. No referral needed for most plans.
Frequently asked questions
What is the difference between melanoma in situ and invasive melanoma? In situ means cancer stays in the top skin layer. It cannot spread while it stays truly in situ. Removing it with clear edges usually cures it. Invasive means it has grown deeper and can spread. Ask which type you have, since care differs.
Is melanoma curable? Most early cases are cured with surgery. The stage and depth help predict the outlook. That is why a new or changing spot needs a check.2
Will I need chemotherapy? For most early melanoma, no. Surgery is the main treatment. For advanced disease, immune drugs or targeted pills are often used first. Chemotherapy may still be used in selected cases. An oncology team helps choose the plan.3
What is a sentinel lymph node biopsy? It checks the first lymph node the melanoma would drain to. It is mainly a staging test. It helps predict outlook and guide further care. The team considers depth and other risk features when offering it.9 If that node is involved, watching the nodes with ultrasound is now often chosen, since removing all of them did not improve survival in a trial.10
How wide a margin will be removed? The margin is based on depth. A thin tumor usually needs less skin removed than a thick one. One trial of melanomas thicker than 2 mm found no survival difference between 2-cm and 4-cm margins. That does not mean every narrower margin is equally safe.6 Your clinician will explain the plan for your melanoma.
Questions to ask your clinician
- Is my melanoma in situ, invasive, or advanced, and what stage is it?
- How thick is it, and do I need a sentinel lymph node biopsy?
- What margin will be removed, and what will the scar look like?
- Do I need to see an oncologist, and for what?
- How often should I have skin checks now, and what should I watch for?
Early diagnosis helps guide care. Related guides cover melanoma in situ, lentigo maligna, atypical (dysplastic) moles, and surgical excision. A thorough skin cancer screening is the place to start.
Reviewed by Tyler Long, DO. Last reviewed November 3, 2026.
Update log
How this guide has changed since it was first published.
- November 3, 2026Clarified stage and treatment descriptions, prevention uncertainty, and patient safety information. Reviewed and accepted for publication November 3, 2026.
- August 4, 2026Guide published.
References
Sources supporting this guide are listed below, with links to the publications or issuing organizations. Numbers match the citations in the text and the grids above.
- Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49.View source
- Swetter SM, Tsao H, Bichakjian CK, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2019;80(1):208–250.View source
- National Cancer Institute. Melanoma Treatment (PDQ®): Health Professional Version. National Cancer Institute. Accessed November 3, 2026.View source
- Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: Evidence-based changes in the AJCC eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–492.View source
- Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350(8):757–766.View source
- Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet. 2011;378(9803):1635–1642.View source
- Patel SP, Othus M, Chen Y, et al. Neoadjuvant–adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med. 2023;388(9):813–823.View source
- Andtbacka RHI, Kaufman HL, Collichio F, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33(25):2780–2788.View source
- Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609.View source
- Faries MB, Thompson JF, Cochran AJ, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211–2222.View source
- Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824–1835.View source
- Larkin J, Chiarion-Sileni V, Gonzalez R, et al. Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. N Engl J Med. 2019;381(16):1535–1546.View source
- Robert C, Grob JJ, Stroyakovskiy D, et al. Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma. N Engl J Med. 2019;381(7):626–636.View source
- Croaker A, Liu L, Myers SP. Persisting cancer in black salve treated skin lesions: results of a large 5-year retrospective analysis of Australian histopathology specimens. Integr Cancer Ther. 2023;22:15347354221151145.View source
- Leecy TN, Beer TW, Harvey NT, et al. Histopathological features associated with application of black salve to cutaneous lesions: a series of 16 cases and review of the literature. Pathology. 2013;45(7):670–674.View source
- Feldstein S, Afshar M, Krakowski AC. Chemical burn from vinegar following an internet-based protocol for self-removal of nevi. J Clin Aesthet Dermatol. 2015;8(6):50.View source
- National Center for Complementary and Integrative Health. Cancer and Complementary Health Approaches: What You Need To Know. National Institutes of Health. Accessed November 3, 2026.View source
- Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–263.View source
